Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055874
Status:
COMPLETED
Last Update Posted:
2018-05-03
First Post:
2003-03-06
Brief Title:
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor:
Heidelberg University
Organization:
Heidelberg University
Organization Data
Organization:
Heidelberg University
Class:
OTHER
Study ID:
III-MK-CML-IV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Heidelberg University
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dr Dr hc R Hehlmann
Responsible Party Title:
Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Heidelberg University
Old Name:
None
Old Organization:
None